Skip to main content

VAXCHORA (Biocelect Pty Ltd)

Product name
Date registered
Evaluation commenced
Decision date
Approval time
209 (255 working days)
Active ingredients
Vibrio cholerae
Registration type

VAXCHORA vaccine is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older travelling to cholera-affected countries.

VAXCHORA vaccine should be used in accordance with official recommendations.

The vaccine should not replace standard preventive hygiene measures.

Help us improve the Therapeutic Goods Administration site